pharmaphorum’s digital magazine Deep Dive is published in online and pdf versions six times a year and reaches a global audience of highly engaged pharmaceutical and biotechnology decision-makers.

Each Deep Dive issue combines a focus topic – either sales and marketing, digital, market access, oncology, patients or R&D – with an additional mixture of thought-provoking content and commercial opportunities include:

• Features (interview style article, up to 2,000 words)
• Features (client-written article, up to 2,000 words
• 12 questions with...
• Case studies
• Company profiles
• Digital advertising
• Edition sponsorship
• Bespoke editions

The Deep Dive team can offer full editorial support in planning and writing articles, including the inclusion of appropriate graphics and links. Articles receive a one-month cycle of promotion and a digital and print PDF versions of articles are provided after the issue is published.

In 2022 the companies that benefitted from this included: Envision, Eversana, Evidation, Frontiers Health, Icon, Ipsen, IQVIA, Lumanity, M3, Medipace, Medscape, Phesi, Research Partnership, Syneos Health, Vinehealth, Viseven, ZS Associates.

Upcoming Deep Dive issues for 2023 will include:

Communications & Commercialisation in 2023

In this issue: The way that stakeholders engage with content is changing, and drugmakers must adapt to this new landscape in order to remain competitive.

With omnichannel, modular content, and digital tools now in the spotlight, how can companies maximise emerging opportunities?

Publication: w/c 22 February

Other upcoming topics:

October 2023: Patients & Partnerships

• Patient experience and engagement
• Improving patient care
• Value through co-creation

Plus:

• Clinical trial innovation
• New models for market access
• Patients in real-world evidence studies and beyond

November 2023: Digital Health Innovation

• Digital-first healthcare
• AI and machine learning in healthcare

Plus:

• Frontiers Health 2023
• Digital health start-ups to watch
• Data-driven drug development

Let us help you connect with your clients, email advertising@pharmaphorum.com or download our media pack for more information about Deep Dive and our other offerings.